Presentation description
Medulloblastoma has been difficult to treat due to its solid tumor type and its immunosuppressive environment. My project proposes that the combination treatment of anti-CD47 and chimeric antigen receptor macrophages, by downregulating the ITIM pathway, enhances phagocytic efficacy against medulloblastoma. To achieve this downregulation, plasmids encoding dominant-negative PTPN6 are introduced into macrophages via lentiviral transduction, silencing PTPN6 RNA.
Presenter Name: Andy Chan
Presentation Type: Poster
Presentation Format: In Person
Presentation #85
College: Medicine
School / Department: Neurosurgery
Research Mentor: Samuel Cheshier
Time: 1:00 PM
Physical Location or Zoom link:
Union Ballroom